Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Conferences | Events

Tecan and Enigma Diagnostics sign licence and collaboration agreement

tecanThe Tecan Group (SIX Swiss Exchange: TECN), a leading global provider of laboratory instruments and solutions, and Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today the signing of a licence and collaboration agreement. The licence provides Tecan with access to specific Enigma intellectual property that is used in Enigma's fully automated, molecular diagnostic system, the Enigma® ML.

The licence enables Tecan to further expand its growing OEM partnering business and develop a next generation molecular diagnostics platform for a potential OEM partner. The envisaged integrated solution includes enabling consumables and is targeted at central laboratories with the goal to provide a unique combination of features such as, random sample access, complete automation from raw sample to result, a small footprint and a rapid time to result.

Thomas Bachmann, CEO of Tecan, said: "We are delighted to have signed this licence agreement with Enigma for their innovative sample preparation and thermocycling technology. The licence provides us with the opportunity to approach a potential OEM partner with our concept of an integrated solution for molecular diagnostics that includes a unique instrument as well as enabling consumables. The licence agreement builds on our existing agreement with Enigma that we signed in February 2010 for the manufacturing and supply of Enigma's ML point-of-care molecular diagnostics instruments."

John McKinley, Chairman and CEO of Enigma, said: "We are very pleased to sign this significant agreement which extends an already strong partnership with Tecan. It demonstrates the capability of Enigma's sample preparation and thermocycling technology to generate a pipeline of next generation molecular diagnostic instruments covering high throughput, central laboratory to point of care settings."

Financial terms were not disclosed.

For further information please viit http://www.tecan.com/


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

Today's Picks

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners